Searching for Solutions

Learn all about Antipsychotic Long-Acting Injectable Preparation, Administration, and Storage! This is one of six modules in our complimentary Psychotropic LAI Training Program. Register today and get access to the full program and LAI resources.

Telehealth utilization increased 10.1% across the U.S. from the fourth quarter of 2025 to the first three months of 2026, a new report from Fair Health found. Telehealth utilization, measured as a percentage of medical claim lines, increased from 5.01% of medical claim lines in the fourth quarter of 2025 to 5.51% in Q1 2026. The relative increase was 12% in the Midwest, 11.8% in the Northeast, 9% in the South and 8.1% in the West, Fair Health data indicated.

Screening for gambling disorder and other psychiatric conditions could help mitigate related harms.

This study developed a quantitative analytical method to measure the blood concentration of xylazine and its metabolites, fentanyl and its metabolite, and medetomidine and its metabolite.

The present findings of this meta-analysis underscore the importance of evaluating a continuum of outcomes rather than focusing solely on abstinence in RCTs.

This publication aims to evaluate the current evidence on BZD tapering and outline key research recommendations.

The U.S. Food and Drug Administration (FDA) approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone hydrochloride nasal spray for the emergency treatment of opioid overdose. Consumers may directly purchase this product without a prescription in places such as pharmacies, convenience stores, and online.

No summary available

In this JAMA Pediatrics article presenting the results of a nationally representative survey study of US adolescents and young adults, a fifth reported using AI chatbots for mental health advice.

This report examines data from the Centers for Disease Control and Prevention (CDC) and other federal sources.

This study of Medicaid records from 29,193 women found that pregnant women who received OUD treatment, including medication, talk-based therapies, or both, had significantly better pregnancy outcomes than those who received no treatment.

Tianeptine or “gas station heroin” is readily available and a public health concern. Access this toolkit focused on mechanism of misuse, clinical presentation, and management of acute intoxication and withdrawal among other timely topics.

Widely known as "gas station heroin," tianeptine is illegal or unapproved for medical use in the U.S. but readily available in unregulated convenience stores and online. AAPP and author Sarah Thomason are providing an important toolkit addressing tianeptine’s mechanism of misuse, clinical presentation, and management of acute intoxication and withdrawal among other topics. Check out this timely member resource today.

Phenibut is sold as a supplement but has a high potential for abuse and dependency. Access this toolkit focused on mechanism of misuse, clinical presentation, and management of acute intoxication and withdrawal among other timely topics.

Sold as a readily available supplement, phenibut is not approved for medical use in the U.S. It has a high potential for abuse and dependency making AAPP’s newest toolkit an important read. Author Sarah Thomason addresses phenibut’s mechanism of misuse, clinical presentation, and management of acute intoxication and withdrawal among other topics. Check out this timely member resource today.

Eliminate confusion about the use of buprenorphine and methadone in acute care settings by accessing an FAQ resource addressing the most common questions and scenarios.

Despite their importance as first-line options for OUD treatment, confusion remains regarding their use in acute care settings, especially when patients seek care at institutions that do not have opioid treatment program (OTP) licensure. AAPP members and authors Zoe Karovolis, Emily Leppien, and Annette Percy have developed a go-to resource addressing frequently asked questions regarding the use of buprenorphine and methadone in acute care settings.

No summary available

These findings suggest that glucagon-like peptide-1 receptor agonist monotherapy may alter some nicotine outcomes in people who smoke, irrespective of cessation treatment.

GLP-1 RA use in adults on methadone with both OUD and T2D was associated with lower rates of cardiometabolic and mental health complications.

Findings suggest brief educational interventions can help primary care providers recognize misinformation that may otherwise undermine implementation efforts.

This study conducted a systematic review following PRISMA 2020 guidelines.

Momentum continued throughout 2025 in the areas of grant support, practitioner development, and sponsorship! View our 2025 Annual Report to see the impact. Thank you to the incredible donors who support this important work.

This blog series by the Resident and New Practitioner Committee is targeted to psychiatric pharmacists seeking their first or a new position. This blog explores opportunities in the pharmaceutical industry.